ClinicalTrials.gg
RecruitingNCT05864664Updated Oct 3, 2023

Safety and Efficacy of Wide Awake Local Anesthesia no Tourniquet Technique (WALANT) in Ankle Removal of Implant Surgery

An interventional study of Wide awake local anaesthesia no tourniquet technique in Safety Issues, Post Operative Pain and Local Anesthetic Complication, sponsored by Ali Lari. Recruiting at 1 site in Kuwait. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-10-03.

Sponsored by Ali Lari · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Nov 2023, 3 years ago, but the record still lists the study as recruiting.
  • Registered 4 months after the study started (first participant enrolled Apr 2022, registered Aug 2022).
  • Started Apr 2022; still recruiting 4 years 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Safety and efficacy of wide awake local anesthesia no torniquet technique (WALANT) in ankle surgery. Studying risks and benefits from WALANT compared to general anesthesia . WALANT expected to decrease in intraoperative/post operative pain at the surgical site and decrease hospital time .

02

Conditions studied

  • Safety Issues
  • Post Operative Pain
  • Local Anesthetic Complication

Browse trials for

03

In context

Pain, Postoperative

5,640 studies on the registry are indexed under Pain, Postoperative; 1,230 are open to participants now.

This study's planned enrollment of 40 is below the median of 75 across 4,821 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

This is the only study on the registry with Ali Lari as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age: >18
  • Previous ORIF for:
  • Unimalleolar fractures
  • Bimalleolar fractures
  • Trimalleolar fractures

Exclusion criteria

Exclusion Criteria:

  • Allergy to local anesthesia
  • Psychiatric diagnosis including: affect disorders, uncooperative
  • Severe cardiovascular disease
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    WALANT procedure

    Patient awake with no form of sedation or analgesia A mixture of lidocaine, adrenaline, normal saline, bicarbonate is used to get 40-50ml solution Injection is performed around incision site - superficial to deep including periosteum Incision is performed in the normal fashion Plate and screws are removed and incision is closed

    Procedure: Wide awake local anaesthesia no tourniquet technique

  • Active comparator
    General anesthesia

    The surgery is performed in the standard fashion. The patient received general anesthesia The surgery is performed normally and the plate/screws are removed

    Procedure: Wide awake local anaesthesia no tourniquet technique

Interventions

  • ProcedureWide awake local anaesthesia no tourniquet technique

    Patient awake with no form of sedation or analgesia * A mixture of lidocaine, adrenaline, normal saline, bicarbonate is used to get 40-50ml solution * Injection is performed around incision site - superficial to deep including periosteum * Incision is performed in the normal fashion * Plate and screws are removed and incision is closed

06

What researchers measure

Primary outcomes

  1. Evaluation of the patient's maximum pain intraoperatively at the surgical site

    Visual analogue pain scale - VAS

    Time frame: Intraoperative

  2. Blood loss

    Amount cc

    Time frame: Intraoperative

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 3, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05864664
Lead sponsor
Ali Lari
Responsible party
Ali Lari (Dr Ali Lari - MB BCh BAO, Kuwait Institute for Medical Specialization) — Sponsor-investigator
First posted
May 18, 2023
Start date
Apr 1, 2022
Primary completion
Nov 1, 2023 (estimated)
Completion
Nov 1, 2023 (estimated)
Last update
Oct 3, 2023

Study contacts

Ali Lari, MD
Contact
dr.alilari@gmail.com
+96566428328
Ali Jarragh, MD FRCS.C
principal investigator · Kuwait University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion